Crossmark

Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease

Crossref DOI link: https://doi.org/10.1186/s12916-018-1159-7

Published Online: 2018-10-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Hyun

Shin, Sun Hye

Gu, Seonhye

Zhao, Di

Kang, Danbee

Joi, Yeong Rae

Suh, Gee Young

Pastor-Barriuso, Roberto

Guallar, Eliseo

Cho, Juhee

Park, Hye Yun
License Information

Text and Data Mining valid from 2018-10-04
More Information

Article History

Received: 13 January 2018

Accepted: 22 August 2018

First Online: 4 October 2018

Ethics approval and consent to participate

: As we used publicly available data, our institutions waived the need for ethical approval. The original U.S. NHANES and KNHANES surveys we used were approved by the relevant institutional review boards and all participants provided written, informed consent.

: Not applicable.

: HYP has received lecture fees from AstraZeneca, Novartis, and Boehringer-Ingelheim. HL, SHS, SG, DZ, DK, YRJ, GYS, RP, EG, and JC have no competing interests to declare.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.